- Home
- CSR vs IMTX Comparison
CSR vs IMTX Comparison
Compare CSR & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSR
- IMTX
- Stock Information
- Founded
- CSR 1970
- IMTX N/A
- Country
- CSR United States
- IMTX Germany
- Employees
- CSR N/A
- IMTX N/A
- Industry
- CSR Real Estate Investment Trusts
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSR Real Estate
- IMTX Health Care
- Exchange
- CSR Nasdaq
- IMTX Nasdaq
- Market Cap
- CSR 1.1B
- IMTX 954.2M
- IPO Year
- CSR N/A
- IMTX N/A
- Fundamental
- Price
- CSR $66.01
- IMTX $6.85
- Analyst Decision
- CSR Buy
- IMTX Strong Buy
- Analyst Count
- CSR 7
- IMTX 4
- Target Price
- CSR $71.50
- IMTX $16.67
- AVG Volume (30 Days)
- CSR 146.2K
- IMTX 516.6K
- Earning Date
- CSR 10-28-2024
- IMTX 11-18-2024
- Dividend Yield
- CSR 4.54%
- IMTX N/A
- EPS Growth
- CSR N/A
- IMTX N/A
- EPS
- CSR N/A
- IMTX N/A
- Revenue
- CSR $258,642,000.00
- IMTX $128,824,447.00
- Revenue This Year
- CSR N/A
- IMTX $120.90
- Revenue Next Year
- CSR $3.55
- IMTX N/A
- P/E Ratio
- CSR N/A
- IMTX N/A
- Revenue Growth
- CSR N/A
- IMTX 52.53
- 52 Week Low
- CSR $20.10
- IMTX $6.68
- 52 Week High
- CSR $76.16
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- CSR 31.30
- IMTX 27.51
- Support Level
- CSR $68.88
- IMTX $6.68
- Resistance Level
- CSR $69.36
- IMTX $7.40
- Average True Range (ATR)
- CSR 1.63
- IMTX 0.33
- MACD
- CSR -0.60
- IMTX -0.03
- Stochastic Oscillator
- CSR 23.31
- IMTX 10.43
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and they conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.